Today: 9 June 2026
Browse Category

ASX:LYC.AX 8 January 2026 - 17 February 2026

Lynas Rare Earths share price jumps after Trump’s Project Vault shakes up rare earth supply talk

Lynas Rare Earths share price jumps after Trump’s Project Vault shakes up rare earth supply talk

Lynas Rare Earths shares rose 3.3% to A$15.25 Tuesday after Trump’s “Project Vault” mineral reserve plan and ahead of further White House comments. The stock rebounded from last week’s drop, when reports of a U.S. retreat from price floor talks triggered sharp losses across the sector. Japan recovered rare-earth-rich seabed mud, while TDK warned of Chinese export limits disrupting supplies. Lynas quarterly revenue rose to A$201.9 million despite lower output.
3 February 2026
··
Lynas Rare Earths share price sinks 6% — what investors watch before the Jan. 21 update

Lynas Rare Earths share price sinks 6% — what investors watch before the Jan. 21 update

Lynas Rare Earths Ltd fell 6.3% to A$15.25 Tuesday, with over A$100 million traded ahead of its quarterly results due Wednesday. The drop came as rare-earth magnet exports from China to Japan slipped 8% in December and the ASX 200 lost 0.66%. CEO Amanda Lacaze is set to retire at the end of the financial year. Investors await updates on sales, pricing, and plant operations.
20 January 2026
·
Lynas Rare Earths stock jumps after CEO retirement plan as rare-earth supply talks heat up

Lynas Rare Earths stock jumps after CEO retirement plan as rare-earth supply talks heat up

Lynas Rare Earths shares rose 3.3% to A$15.56 Wednesday, extending a three-day rally after CEO Amanda Lacaze announced plans to retire after 12 years. Lacaze will remain until the end of the financial year while the board seeks a replacement. The leadership change comes as Australia unveils a A$1.2 billion strategic reserve for critical minerals and G7 finance ministers discuss reducing reliance on Chinese rare earths.
14 January 2026
··
Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths dropped 5.4% to A$14.24 on Thursday, reversing part of Wednesday’s 14.5% surge after China banned exports of “dual-use” items to Japan. The stock traded 8.36 million shares as investors weighed risks to rare earth supply. G7 finance ministers will meet Jan. 12 to discuss supply and a possible price floor. Lynas will report quarterly results Jan. 21.
8 January 2026
·

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop